Column
The antiviral molnupiravir, a major breakthrough in the treatment of COVID-19
The pharmaceutical Merck recently announced that its antiviral drug molnupiravir is halving the hospitalizations and mortality of patients most at risk of developing severe forms of COVID-19. Download the column
12-Oct-2021 |
Recent Articles